Selected data models

You must log in to select data models for download or further analysis.

19 Search results.
Relevance Rating New first Old first

Sleep Apnea - Child Protocol PhenX Toolkit

- 9/20/21 - 1 form, 6 itemgroups, 106 items, 1 language
Itemgroups: PhenX - respiratory - sleep apnea - child protocol, Long - term medical problem, Medication list, Psychological, psychiatric, emotional, or behavioral problem, Sleep disorders, Sleep or behavior disorders relatives
The Pediatric Sleep Questionnaire (PSQ) protocol is a parent questionnaire for children from 2 through 18 years, and rated on a simple three-point scale ("yes," "no," or "don’t know") for all items except the inattention/hyperactivity items that are rated on a four-point Likert scale. This protocol provides an overall total score and five sleep scales: (1) Sleep-Related Breathing Disorders (SRBD), (2) Snoring, (3) Sleepiness, (4) Behavior, and (5) Periodic Limb Movement Disorder (PLMD). ODM derived from: https://cde.nlm.nih.gov Primary source: https://www.phenxtoolkit.org/ Recent publication: Hendershot, T., Pan, H., Haines, J., Harlan, W.R., Marazita, M.L., McCarty, C.A., Ramos, E.M., and Hamilton, C.M. (2015) Using the PhenX toolkit to add standard measures to a study. Curr. Protoc. Hum. Genet. 86:1.21.1-1.21.17. doi: 10.1002/0471142905.hg0121s86 Permission to publish granted by Carol M. Hamilton.

Eligibility Sleep Initiation and Maintenance Disorders NCT00227942

- 9/20/21 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia; ODM derived from: https://clinicaltrials.gov/show/NCT00227942

Eligibility Mood Disorder NCT00616915

- 5/29/17 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Does Sleep Quality Change After Switch From Wellbutrin SR to Wellbutrin XL in Patients With Major Depressive Disorder?; ODM derived from: https://clinicaltrials.gov/show/NCT00616915

Eligibility Sleep Disorder NCT02002533

- 7/8/19 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT02002533

Eligibility Excessive Daytime Sleepiness NCT00642928

- 9/17/21 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00642928

Eligibility Insomnia NCT01256099

- 1/3/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Internet-CBT for Insomnia; ODM derived from: https://clinicaltrials.gov/show/NCT01256099

Eligibility Sleep-disordered Breathing NCT00863421

- 10/29/18 - 1 form, 2 itemgroups, 21 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Sleep Disordered Breathing in Patients With Chronic Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT00863421

Eligibility Sleep Initiation and Maintenance Disorders NCT00495885

- 9/2/17 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00495885

Eligibility Sleep Initiation and Maintenance Disorders NCT00464061

- 9/1/17 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00464061

dbGaP phs001270 Sleep and Circadian Disorders Study (SACDS) - pht006249.v1.p1

- 11/11/24 - 6 forms, 1 itemgroup, 4 items, 1 language
Itemgroup: pht006249
Principal Investigator: Ying-Hui Fu, PhD, University of California San Francisco, San Francisco, CA, USA MeSH: Sleep Wake Disorders,Short Sleeper Syndrome,Long Sleeper Syndrome,CLOCK Proteins,Circadian Clocks https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001270 Sleep is essential for life. A good night's sleep is pleasurable and sleep deprivation is stressful. Prolonged sleep loss impairs temperature control, metabolism, immunity, and ultimately leads to death. Extensive observational and epidemiological evidence indicates that optimal sleep duration of 8 hours is associated with the maintenance of good health. In our society, however, most people only get 6.5 - 7 hours. Suboptimal sleep duration has a strong association with mortality and morbidity. Lack of sleep has been linked to cardiovascular diseases, obesity, hypertension, type 2 diabetes, and other health/cognition conditions. It is clear that the biological need for sleep varies dramatically among humans. Sleep and circadian disorders can include Familial Advanced Sleep Phase (FASP), Delayed Sleep Phase (DSP), Advanced Sleep Phase (ASP), Natural Short Sleepers (NSS) or Long Sleeping. In example, Natural Short Sleepers (NSS) have a lifelong tendency to sleep only 4 - 6 hours per night and to awaken refreshed and energetic. Natural Long Sleepers biologically require 9 - 10 hours/night to feel well rested. The 'Sleep and Circadian Disorders Study' (SACDS) at the University of California San Francisco, set out to investigate the mechanisms involved in regulating sleep duration, patterns and sleep quality regulation by identifying and characterization of individuals and families with unusual sleep and circadian rhythm behavior patterns. SACDS participants were screened with a "General Sleep Questionnaire" that inquired about multiple aspects of sleep, including habitual work-day versus non-work day sleep-wake schedules, permits calculation of subjective habitual initial sleep onset, final sleep offset, and number of awakenings. There was an additional screening process including demographic data, sleep, mood, behavioral and general medical questionnaires, plus the study consent. After the extensive screening of 117 participants, blood samples were collected from 38 individuals and of those 10 samples were chosen for whole exome sequencing analysis.

pht006250.v1.p1

1 itemgroup 5 items

pht006251.v1.p1

1 itemgroup 5 items

pht006252.v1.p1

1 itemgroup 5 items

pht006253.v1.p1

1 itemgroup 7 items

F.0

2 itemgroups 5 items

Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia - Eligibility

- 9/27/21 - 1 form, 2 itemgroups, 51 items, 2 languages
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00247390

Eligibility Sleep Disorders in Pulmonary Arterial Hypertension NCT01371669 - Eligibility Sleep Disorders in Pulmonary Arterial HypertensionNCT01371669

- 9/28/20 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Screening for Sleep Hypoxemia in Pulmonary Arterial Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01371669

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial